发明名称 |
Sertraline salts and sustained-release dosage forms of sertraline |
摘要 |
Sustained release dosage forms of sertraline, or pharmaceutically acceptable salts thereof are disclosed. Sertraline is released at a rate of between 0.02 mgA/hr/kg and 0.6 mgA/hr/kg, or between 1 mgA/hr and 40 mgA/hr, where mgA is the amount of active sertraline. The dosage form must not release more than 70% of the sertraline in the first hour following administration. The dosage form is suitable for oral administration to a mammal.
|
申请公布号 |
NZ501251(A) |
申请公布日期 |
2001.09.28 |
申请号 |
NZ19980501251 |
申请日期 |
1998.06.15 |
申请人 |
PFIZER INC |
发明人 |
FRIESEN, DWAYNE THOMAS;WEST, JAMES BLAIR;HERBIG, SCOTT MAX;AM ENDE, MARY TANYA;CURATOLO, WILLIAM JOHN;FRIEDMAN, HYLAR LEWIS;SHANKER, RAVI MYSORE |
分类号 |
A61K9/22;A61K;A61K9/00;A61K9/16;A61K9/20;A61K9/26;A61K9/28;A61K9/32;A61K9/50;A61K9/52;A61K9/54;A61K31/135;A61P3/04;A61P25/18;A61P25/24;A61P25/30;C07C209/00;C07C211/42;C07D;(IPC1-7):A61K31/135 |
主分类号 |
A61K9/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|